“We applaud today’s signing of the ‘Bali Healthcare Stakeholders Statement on Fostering Ethical Environments in the Medical Device and Biopharmaceutical Sectors..."
In FY 2013 alone $2.9 million in medical device user fees will not be available to the agency, and going forward, additional user fees are at risk because of sequestration.
“We call on the Congress to quickly consider and pass this important legislation and to continue to work to release the user fees from FY2013 which have been sequestered.”
The Coalition of Small Business Innovators (CSBI) released a study today showing that the three proposals supported by the group would increase total investment in small businesses by $20.6 billion and result in an estimated 623,000 jobs.
“AdvaMed would like to thank Reps. Leonard Lance (R-NJ), Anna Eshoo (D-CA), Doris Matsui (D-CA), Mike Rogers (R-MI) and the other co-sponsors of this legislation, which will allow FDA to have full access to the user fees paid by medical technology companies and other FDA-regulated industries."
“Repealing the device tax has strong bipartisan support and is the first step to corporate tax reform. Medical technology companies across the country are struggling to remain competitive and this tax makes their effort to grow, innovate and invest in the future that much harder,” said Stephen J. Ubl, President and CEO of AdvaMed.
Leaders of New York’s bioscience and medical technology industry joined U.S. Rep. Bill Owens (D-NY) today to address how companies within the sector can drive the state’s economic competitiveness and future growth.
“Legislative measures to repeal the device tax passed the House last summer and the Senate in March with overwhelming bipartisan majorities. Congress and the President must act now to finish the job and repeal it.”
“Patient safety is the number one priority of the medical technology industry, and manufacturers have in place numerous safeguards to ensure the security and integrity of their devices..."
"CMS is a critical agency, and it needs a permanent administrator to lead it during this time of major change. Her deep experience in health care and her record of respectfully working with all the major stakeholders make her an excellent choice to lead CMS..."